| |
British journal of pharmacology, Vol. 139, No. 4. (June 2003), pp. 715-720.
|
| |
J. Nutr., Vol. 135, No. 4. (1 April 2005), pp. 707-713.
|
| |
Journal of Thrombosis and Haemostasis, Vol. 6, No. 6. (June 2008), pp. 976-985.
|
| |
Proc West Pharmacol Soc, Vol. 47 (2004), pp. 54-56.
|
| |
Am J Physiol Lung Cell Mol Physiol, Vol. 288, No. 3. (1 March 2005), pp. L530-535.
|
| |
Heart, Vol. 94, No. 4. (1 April 2008), pp. 487-492.
by F. Cosentino, D. Hurlimann, Delli, et al.R. Chenevard, N. Blau, N. J. Alp, K. M. Channon, M. Eto, P. Lerch, F. Enseleit, F. Ruschitzka, M. Volpe, T. F. Luscher, G. Noll
|
| |
Diabetic Medicine, Vol. 25, No. 3. (March 2008), pp. 320-325.
|
| |
Endocrine Abstracts, Vol. 14 (2007), 275.
|
| |
Environmental Health Perspectives (31 July 2008)
by Alexandra Schneider, Lucas Neas, Margaret C. Herbst, et al.Martin Case, Ronald W. Williams, Wayne Cascio, Alan Hinderliter, Fernando Holguin, John B. Buse, Kathleen Dungan, Myna Styner, Annette Peters, Robert B. Devlin
|
| |
American Journal of Therapeutics, Vol. 15, No. 4., pp. 326-333.
by Valmore M. D. Bermudez, Fernando M. D. Bermudez, Guillermo M. D. Acosta, et al.Alejandro M. S. Acosta, Johnny M. S. Anez, Carla M. S. Andara, Elliuz M. D. Leal, Climaco P. Cano, Velasco P. Manuel, Rafael M. D. Hernandez, Zafar P. Israili
|
| |
Cardiovascular Research, Vol. 34, No. 1. (1997), pp. 145-156.
|
| |
Journal of cardiovascular pharmacology, Vol. 32, No. 1. (July 1998), pp. 101-105.
|
| |
The Journal of clinical investigation, Vol. 112, No. 5. (September 2003), pp. 725-735.
|
| |
Am J Physiol Heart Circ Physiol, Vol. 294, No. 5. (1 May 2008), pp. H2098-2105.
|